Researchers
Alireza R. Rezaie and Peyman Dinervand
Summary
Peritoneal dialysis is an alternative to hemodialysis as a treatment for end-stage renal disease and is based on the use of the peritoneum as a permeable membrane whereby ultrafiltration and diffusion between dialysate and blood can take place across the peritoneum. During continuous ambulatory peritoneal dialysis (CAPD) chronic injury occurs which leads to failure of filtration. This invention relates to the use of activated Protein C (APC) as a therapeutic drug for inhibiting dialysis-mediated peritoneal fibrosis.
Intellectual Property Status
- U.S. patent pending